DCGI nod to Serum-Oxford covid-19 vaccine for phase 2, 3 clinical trials in India

"After a thorough evaluation, the DCGI has given approval to SII to perform phase-II, III clinical trial based on the recommendations of the Subject Expert Committee (SEC)," the official source told ANI.